168 related articles for article (PubMed ID: 18181189)
1. Application of flow cytometry for biomarker-based cervical cancer cells detection.
Ling J; Wiederkehr U; Cabiness S; Shroyer KR; Robinson JP
Diagn Cytopathol; 2008 Feb; 36(2):76-84. PubMed ID: 18181189
[TBL] [Abstract][Full Text] [Related]
2. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
4. Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.
Ostrowska KM; Garcia A; Meade AD; Malkin A; Okewumi I; O'Leary JJ; Martin C; Byrne HJ; Lyng FM
Analyst; 2011 Apr; 136(7):1365-73. PubMed ID: 21290054
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections.
von Knebel Doeberitz M; Reuschenbach M; Schmidt D; Bergeron C
Expert Rev Proteomics; 2012 Apr; 9(2):149-63. PubMed ID: 22462787
[TBL] [Abstract][Full Text] [Related]
6. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection.
Malinowski DP
Expert Rev Mol Diagn; 2007 Mar; 7(2):117-31. PubMed ID: 17331061
[TBL] [Abstract][Full Text] [Related]
7. Traditional and new molecular methods for early detection of cervical cancer.
Dallenbach-Hellweg G; Trunk MJ; von Knebel Doeberitz M
Arkh Patol; 2004; 66(5):35-9. PubMed ID: 15575385
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 in post-radiotherapy cervical biopsies.
El-Bahrawy M
Histopathology; 2011 Jun; 58(7):1174-6. PubMed ID: 21707719
[No Abstract] [Full Text] [Related]
9. [Interest of new biomarkers in cervical precancerous lesion management].
Dachez R
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S152-4. PubMed ID: 18191337
[TBL] [Abstract][Full Text] [Related]
10. Rapid, high throughput determination of cervical cytology specimen adequacy using a capillary-based cytometer.
Polina R; Sturgis C; Patterson J; Patterson BK
Cytometry B Clin Cytom; 2008 Mar; 74(2):133-6. PubMed ID: 18044721
[TBL] [Abstract][Full Text] [Related]
11. Use of flow cytometry as a quality control device for liquid-based cervical cytology specimens.
Kottaridi C; Georgoulakis J; Kassanos D; Pappas A; Spathis A; Margari N; Aninos D; Karakitsos P
Cytometry B Clin Cytom; 2010 Jan; 78(1):37-40. PubMed ID: 19746413
[TBL] [Abstract][Full Text] [Related]
12. Transition of cervical carcinoma in situ to invasive cancer: role of p16 INK4a expression in progression and in recurrence.
Anschau F; Schmitt VM; Lambert AP; Gonçalves MA; Machado DC
Exp Mol Pathol; 2009 Feb; 86(1):46-50. PubMed ID: 19100258
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic-based diagnostics for cervical cancer cells.
Du Z; Colls N; Cheng KH; Vaughn MW; Gollahon L
Biosens Bioelectron; 2006 Apr; 21(10):1991-5. PubMed ID: 16242927
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
16. [Two cytological methods for screening for cervical cancer].
Kirschner B; Simonsen K; Junge J
Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
[TBL] [Abstract][Full Text] [Related]
17. Review of screening and preventive strategies for cervical cancer in India.
Patro BK; Nongkynrih B
Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
[TBL] [Abstract][Full Text] [Related]
18. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
19. Combined serial section-based 3D reconstruction of cervical carcinoma invasion using H&E/p16INK4a/CD3 alternate staining.
Wentzensen N; Braumann UD; Einenkel J; Horn LC; von Knebel Doeberitz M; Löffler M; Kuska JP
Cytometry A; 2007 May; 71(5):327-33. PubMed ID: 17279561
[TBL] [Abstract][Full Text] [Related]
20. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
